These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 34554836)

  • 1. Cost effectiveness of a specialist wound care service.
    Rivolo M; Staines K
    J Wound Care; 2021 Sep; 30(9):685-692. PubMed ID: 34554836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A service evaluation to examine the use of compression strapping for the management of patients with retromalleolar leg ulcers in a specialist community setting.
    Haynes S; Holloway S
    Int Wound J; 2022 Aug; 19(5):1232-1242. PubMed ID: 34753216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early versus deferred endovenous ablation of superficial venous reflux in patients with venous ulceration: the EVRA RCT.
    Gohel MS; Heatley F; Liu X; Bradbury A; Bulbulia R; Cullum N; Epstein DM; Nyamekye I; Poskitt KR; Renton S; Warwick J; Davies AH
    Health Technol Assess; 2019 May; 23(24):1-96. PubMed ID: 31140402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of using intermittent pneumatic compression to manage hard-to-heal venous leg ulcers in the UK.
    Guest JF; Staines K; Murphy N
    J Wound Care; 2021 Jul; 30(7):544-552. PubMed ID: 34256598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modelling the relative cost-effectiveness of amelogenin in non-healing venous leg ulcers.
    Guest JF; Nagy E; Sladkevicius E; Vowden P; Price P
    J Wound Care; 2009 May; 18(5):216, 218-24. PubMed ID: 19440174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcomes and cost-effectiveness of three alternative compression systems used in the management of venous leg ulcers.
    Guest JF; Gerrish A; Ayoub N; Vowden K; Vowden P
    J Wound Care; 2015 Jul; 24(7):300, 302-5, 307-8, passim. PubMed ID: 26198552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cost-effectiveness analysis of a hydration response technology dressing in the treatment of venous leg ulcers in the UK.
    Walzer S; Dröschel D; Vollmer L; Atkin L; Ousey K
    J Wound Care; 2018 Mar; 27(3):166-172. PubMed ID: 29509113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An advanced self-care delivery model for leg ulcer management: a service evaluation.
    Hallas-Hoyes L; Williamson S; Kerr A; Andrews T; Calladine L
    J Wound Care; 2021 Sep; 30(9):751-762. PubMed ID: 34554835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of Debrichem in managing hard-to-heal venous leg ulcers in the UK.
    Guest JF; Deanesi V; Segalla A
    J Wound Care; 2022 Jun; 31(6):480-491. PubMed ID: 35678784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interventions for helping people adhere to compression treatments for venous leg ulceration.
    Weller CD; Buchbinder R; Johnston RV
    Cochrane Database Syst Rev; 2013 Sep; (9):CD008378. PubMed ID: 24009097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Venous leg ulcer management in clinical practice in the UK: costs and outcomes.
    Guest JF; Fuller GW; Vowden P
    Int Wound J; 2018 Feb; 15(1):29-37. PubMed ID: 29243398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcomes and cost-effectiveness of three different compression systems in newly-diagnosed venous leg ulcers in the UK.
    Guest JF; Fuller GW; Vowden P
    J Wound Care; 2017 May; 26(5):244-254. PubMed ID: 28475441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health economic burden that different wound types impose on the UK's National Health Service.
    Guest JF; Ayoub N; McIlwraith T; Uchegbu I; Gerrish A; Weidlich D; Vowden K; Vowden P
    Int Wound J; 2017 Apr; 14(2):322-330. PubMed ID: 27229943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors related to the failure of venous leg ulcers to heal with compression treatment.
    Milic DJ; Zivic SS; Bogdanovic DC; Karanovic ND; Golubovic ZV
    J Vasc Surg; 2009 May; 49(5):1242-7. PubMed ID: 19233601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bilayered bioengineered skin substitute (Apligraf): a review of its use in the treatment of venous leg ulcers and diabetic foot ulcers.
    Curran MP; Plosker GL
    BioDrugs; 2002; 16(6):439-55. PubMed ID: 12463767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VenUS I: a randomised controlled trial of two types of bandage for treating venous leg ulcers.
    Iglesias C; Nelson EA; Cullum NA; Torgerson DJ;
    Health Technol Assess; 2004 Jul; 8(29):iii, 1-105. PubMed ID: 15248939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relative cost-effectiveness of a skin protectant in managing venous leg ulcers in the UK.
    Guest JF; Taylor RR; Vowden K; Vowden P
    J Wound Care; 2012 Aug; 21(8):389-94, 396-8. PubMed ID: 22885312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of an electroceutical device in treating non-healing venous leg ulcers: results of an RCT.
    Guest JF; Singh H; Rana K; Vowden P
    J Wound Care; 2018 Apr; 27(4):230-243. PubMed ID: 29637824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maggots as a wound debridement agent for chronic venous leg ulcers under graduated compression bandages: A randomised controlled trial.
    Davies CE; Woolfrey G; Hogg N; Dyer J; Cooper A; Waldron J; Bulbulia R; Whyman MR; Poskitt KR
    Phlebology; 2015 Dec; 30(10):693-9. PubMed ID: 25300315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness analysis of guideline-based optimal care for venous leg ulcers in Australia.
    Cheng Q; Gibb M; Graves N; Finlayson K; Pacella RE
    BMC Health Serv Res; 2018 Jun; 18(1):421. PubMed ID: 29880046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.